Envision Healthcare Holdings, Inc. (NYSE: EVHC) (the "Company")
announced today the pricing of a secondary offering of 27.5 million
shares of its common stock by certain stockholders of the Company at a
public offering price of $34.00 per share. Investment funds sponsored
by, or affiliated with, Clayton, Dubilier & Rice, LLC ("CD&R") and
certain executive officers, directors and employees of the Company will
be the selling stockholders. In connection with the offering, the CD&R
investment funds have granted the underwriters an option to purchase up
to 4.125 million additional shares of common stock. The Company will not
receive any proceeds from the secondary offering. The secondary offering
will be made only by means of a prospectus.
Goldman, Sachs & Co., Barclays, BofA Merrill Lynch and Citigroup are
serving as lead joint book-running managers and as representatives of
the underwriters for the secondary offering.
When available, copies of the final prospectus relating to the secondary
offering may be obtained from Goldman, Sachs & Co., Attention:
Prospectus Department, 200 West Street, New York, New York 10282, or by
telephone at 1-866-471-2526, or by facsimile at 1-212-902-9316 or by
email at firstname.lastname@example.org;
Barclays, c/o Broadridge Financial Solutions, 1155 Long Island Avenue,
Edgewood, NY 11717, or by telephone at (888) 603-5847, or by e-mail at email@example.com;
BofA Merrill Lynch, 222 Broadway, New York, NY 10038, Attn: Prospectus
Department or by email at firstname.lastname@example.org;
or Citigroup, c/o Broadridge Financial Solutions, 1155 Long Island
Avenue, Edgewood, NY 11717, or by telephone at (800) 831-9146, or by
A registration statement relating to these securities has been filed
with, and declared effective by, the Securities and Exchange Commission.
This press release shall not constitute an offer to sell or a
solicitation of an offer to purchase these shares or any other
securities, and shall not constitute an offer, solicitation or sale in
any state or jurisdiction in which such an offer, solicitation or sale
would be unlawful.
About Envision Healthcare Holdings, Inc.
Envision Healthcare Holdings, Inc. and our more than 30,000 employees
and affiliated clinicians, offer an array of healthcare related services
to consumers, hospitals, healthcare systems, health plans and local,
state and national government entities. The Company operates American
Medical Response, Inc. ("AMR"), EmCare Holdings, Inc. ("EmCare") and
Evolution Health, LLC ("Evolution Health"). AMR is a provider and
manager of community-based medical transportation services, including
emergency ('911'), non-emergency, managed transportation, fixed-wing air
ambulance and disaster response. EmCare is a provider of integrated
facility-based physician services, including emergency, anesthesiology,
hospitalist/inpatient care, radiology, tele-radiology and surgery.
Evolution Health provides comprehensive care to patients across various
settings, many of whom suffer from advanced illnesses and chronic
diseases. We are headquartered in Greenwood Village, Colorado.
Certain statements and information herein may be deemed to be
"forward-looking statements" within the meaning of the Federal Private
Securities Litigation Reform Act of 1995. Forward-looking statements may
include, but are not limited to, statements relating to the Company's
objectives, plans and strategies, and all statements (other than
statements of historical facts) that address activities, events or
developments that the Company intends, expects, projects, believes or
anticipates will or may occur in the future. Any forward-looking
statements herein are made as of the date of this press release, and the
Company undertakes no duty to update or revise any such statements.
Forward-looking statements are not guarantees of future performance and
are subject to risks and uncertainties. Important factors that could
cause actual results, developments and business decisions to differ
materially from forward-looking statements are described in the
Company's periodic filings with the Securities and Exchange Commission
from time to time, including in the section entitled "Risk Factors" in
the Company's Annual Report on Form 10-K.
[ Back To NFVZone's Homepage ]